AUG 10, 2016 11:50 AM PDT

Bacteria bring the fight to cancer

WRITTEN BY: Kerry Evans
Did you know that bacteria can treat cancer? Well, in a roundabout way, at least.

Since the 1970s, Mycobacterium bovis has been used as part of the Bacillus Calmette-Guerin (BCG) vaccine to treat bladder carcinoma in situ and nonmuscle-invasive bladder cancer.

M. bovis is a rod-shaped bacterium that causes tuberculosis in cattle (that’s the “bovis” part), although it can also infect humans. M. bovis is a close relative of M. tuberculosis, which causes tuberculosis in humans. Humans can contract M. bovis from drinking raw (unpasteurized) cow’s milk. (See, pasteurization is good!)
The BCG vaccine contains attenuated M. bovis.
In the mid 1800s, Robert Koch identified M. bovis as a species distinct from M. tuberculosis. From there, Albert Calmette and Camille Guerin worked to culture M. bovis in the laboratory. Calmette and Guerin wanted to use M. bovis as part of a vaccine against M. tuberculosis. Problem was, M. bovis is just as virulent in humans as M. tuberculosis. This meant that the researchers needed to generate a less virulent strain of M. bovis if there was any hope of using it in a vaccine.
They developed a culture medium to grow the bacteria in - it consisted of glycerin, bile, and potato. The plan was to subculture the bacteria until they isolated an avirulent version.

Thirteen years and 239 subcultures later, they did it. Voila, the BCG vaccine was born.

Ok, back to cancer. How does M. bovis treat cancer? It all has to do with the body’s immune response to the bacteria. The BCG vaccine, which contains live, attenuated M. bovis, is injected into the bladder. There, the immune system elicits a response against the antigens in the vaccine. The exact mechanism of action by which the cancer cells are killed, however, is unknown.

Once the BCG vaccine is administered, the bacteria are taken up by macrophages in the bladder. Curiously, the histologic response in the bladder is the same as the response seen in the lungs when M. bovis causes tuberculosis. The vaccine components are also taken up by the bladder cancer cells. These cells then process and display the BCG antigens on their surface, marking them for killing by immune cells.

It’s not surprising then, that BCG is only effective against bladder cancer if the patient is immunocompetent. BCG is also most effective when the tumor is small and if the vaccine makes direct contact with the tumor cells. If all goes as planned, BCG effectively treats 70% of carcinoma in situ cases. However, longterm maintenance is often necessary to prevent recurrence.

BCG may also be useful against colon cancer. Current research shows some promise when patients are vaccinated with BCG combined with autologous tumor cells.

Because M. bovis is a close relative of M. tuberculosis, BCG is used to vaccinate against tuberculosis in humans. The vaccine is primarily given in countries with a high incidence of tuberculosis. Although data on efficacy vary, a 1994 study found that BCG reduces the risk of contracting TB by roughly 50%. However, a study conducted in 2014 reported that BCG prevented 19-27% of cases of tuberculosis. The same study showed that the vaccine reduced the progression to active TB by roughly 71%, which is certainly good news.

There you go, bacteria can cure cancer. Ok, that’s not exactly true, but you have to admit that the BCG vaccine is pretty cool - as is its origin story.

Sources: American Cancer Society, MedScape, Gastrointestinal Cancers Symposium, Wikipedia
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
MAR 30, 2020
Microbiology
MAR 30, 2020
The Microbial Communities That Form on the Tongue
Scientists used a fluorescent imaging tool to analyze how bacteria grow on the human tongue.
APR 22, 2020
Microbiology
APR 22, 2020
First COVID-19 Death Happened in the US Far Earlier Than We Thought
It was thought that the first death in the US from SARS-CoV-2 happened in Washington State in late February, but autopsi ...
APR 26, 2020
Cell & Molecular Biology
APR 26, 2020
Nose Cells Found to Be Likely SARS-CoV-2 Entry Points
This work may help explain why the virus is so easy to transmit.
MAY 03, 2020
Genetics & Genomics
MAY 03, 2020
Conspiracy Theories Surrounding the Origins of SARS-CoV-2
The origin of SARS-CoV-2, the pandemic virus that causes COVID-19, has become politicized as leaders seek to place blame ...
MAY 17, 2020
Microbiology
MAY 17, 2020
More Research Links ALS to the Microbiome
The community of microorganisms that lives in the gastrointestinal tract has a powerful influence on human health.
MAY 18, 2020
Microbiology
MAY 18, 2020
An Antibody Against SARS May Neutralize SARS-CoV-2
SARS-CoV caused an outbreak of SARS in 2003. Samples collected from those patients back then may help us against SARS-Co ...
Loading Comments...